Superiority of the Triple-Acting 5-HT


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
09 11 2023
Historique:
medline: 10 11 2023
pubmed: 5 10 2023
entrez: 5 10 2023
Statut: ppublish

Résumé

The multifactorial origin and neurochemistry of Alzheimer's disease (AD) call for the development of multitarget treatment strategies. We report a first-in-class triple acting compound that targets serotonin type 6 and 3 receptors (5-HT-Rs) and monoamine oxidase type B (MAO-B) as an approach for treating AD. The key structural features required for MAO-B inhibition and 5-HT

Identifiants

pubmed: 37797083
doi: 10.1021/acs.jmedchem.3c01482
pmc: PMC10641814
doi:

Substances chimiques

Serotonin 333DO1RDJY
3-benzenesulfonyl-8-piperazin-1-ylquinoline 0
Receptors, Serotonin 0
Serotonin Antagonists 0
Monoamine Oxidase EC 1.4.3.4
Monoamine Oxidase Inhibitors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

14928-14947

Références

J Chem Theory Comput. 2011 Mar 8;7(3):625-632
pubmed: 21516178
Future Med Chem. 2017 May;9(8):781-795
pubmed: 28504917
N Engl J Med. 2010 Jan 28;362(4):329-44
pubmed: 20107219
Science. 2021 Aug 6;373(6555):624-626
pubmed: 34353940
Eur J Med Chem. 2018 Jan 20;144:716-729
pubmed: 29291439
Eur J Med Chem. 2020 Dec 15;208:112765
pubmed: 32949963
Neurobiol Aging. 2013 May;34(5):1426-39
pubmed: 23273603
Pharmacol Ther. 2023 May;245:108398
pubmed: 37001735
J Neuroimmunol. 2007 May;186(1-2):181-92
pubmed: 17477976
Science. 1990 Oct 12;250(4978):279-82
pubmed: 2218531
J Med Chem. 2013 Jun 13;56(11):4580-96
pubmed: 23631427
Int J Mol Sci. 2020 May 12;21(10):
pubmed: 32408504
Pharmacol Ther. 2000 Nov;88(2):93-113
pubmed: 11150591
ACS Chem Neurosci. 2019 Aug 21;10(8):3532-3542
pubmed: 31264403
Arch Int Pharmacodyn Ther. 1963 May 1;143:240-6
pubmed: 13975253
Am J Pathol. 2011 Jul;179(1):315-34
pubmed: 21703413
Nat Struct Biol. 2002 Jan;9(1):22-6
pubmed: 11753429
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12310-12315
pubmed: 27791021
Nat Chem Biol. 2014 Jul;10(7):590-7
pubmed: 24880860
Prog Neurobiol. 2020 Oct;193:101846
pubmed: 32512114
EMBO Mol Med. 2016 Jun 01;8(6):595-608
pubmed: 27025652
Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):E3825-30
pubmed: 25157130
J Biol Chem. 2007 Apr 6;282(14):10576-84
pubmed: 17283075
J Chem Theory Comput. 2016 Jan 12;12(1):281-96
pubmed: 26584231
J Med Chem. 2005 Dec 29;48(26):8148-54
pubmed: 16366596
Eur J Med Chem. 2022 Jun 5;236:114329
pubmed: 35397400
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
EMBO Mol Med. 2020 May 8;12(5):e10605
pubmed: 32329240
Curr Drug Targets. 2006 Feb;7(2):165-75
pubmed: 16475958
J Chem Phys. 2010 Apr 21;132(15):154104
pubmed: 20423165
J Neurosci. 1993 Apr;13(4):1676-87
pubmed: 8463843
Neuropharmacology. 2020 Aug 1;172:107839
pubmed: 31682856
Eur J Clin Invest. 2013 Oct;43(10):1039-51
pubmed: 23937291
FASEB J. 2020 Jan;34(1):1150-1168
pubmed: 31914623
Life Sci. 2022 Nov 1;308:120986
pubmed: 36152679
Neuroscience. 2004;129(3):703-18
pubmed: 15541891
Mol Cell. 2022 Jul 21;82(14):2681-2695.e6
pubmed: 35714614
Neurobiol Aging. 2016 Sep;45:109-122
pubmed: 27459932
PLoS One. 2013;8(1):e53117
pubmed: 23301030
J Biomed Sci. 2021 Nov 23;28(1):79
pubmed: 34814918
J Neural Transm Suppl. 2000;(60):157-69
pubmed: 11205137
Sci Adv. 2019 Mar 20;5(3):eaav0316
pubmed: 30906861
Methods Find Exp Clin Pharmacol. 2004 Oct;26(8):615-22
pubmed: 15605121
Nucleic Acids Res. 2012 Jan;40(Database issue):D370-6
pubmed: 21890895
ACS Chem Neurosci. 2016 Jul 20;7(7):972-83
pubmed: 27100049
J Med Chem. 2021 Sep 23;64(18):13279-13298
pubmed: 34467765
Curr Med Chem. 2021;28(29):6045-6065
pubmed: 33538661
J Am Chem Soc. 2001 Jun 20;123(24):5625-31
pubmed: 11403592
Structure. 2020 Oct 6;28(10):1131-1140.e4
pubmed: 32726573
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108
pubmed: 4202581
J Comput Aided Mol Des. 2007 Dec;21(12):681-91
pubmed: 17899391
Neuroscience. 2001;104(4):1003-11
pubmed: 11457586
Elife. 2020 Oct 16;9:
pubmed: 33063666
J Med Chem. 2014 Aug 14;57(15):6679-703
pubmed: 24955776
CNS Drugs. 2017 Jan;31(1):19-32
pubmed: 27914038
Neuroendocrinology. 2022;112(10):982-997
pubmed: 34923495

Auteurs

Katarzyna Grychowska (K)

Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Str., 30-688 Kraków, Poland.

Uriel López-Sánchez (U)

Univ. Grenoble Alpes, CNRS, CEA, IBS, F-38000 Grenoble, France.

Mathieu Vitalis (M)

Molecular Mechanisms in Neurodegenerative Dementia (MMDN) Laboratory, University of Montpellier, EPHE-PSL, INSERM U1198, 34-095 Montpellier, France.

Geoffrey Canet (G)

Faculty of Medicine, Laval University, CR-CHUQ, G1 V 4G2 Québec City (QC), Canada.

Grzegorz Satała (G)

Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Str., 31-324 Kraków, Poland.

Agnieszka Olejarz-Maciej (A)

Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Str., 30-688 Kraków, Poland.

Joanna Gołębiowska (J)

Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Str., 31-324 Kraków, Poland.

Rafał Kurczab (R)

Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Str., 31-324 Kraków, Poland.

Wojciech Pietruś (W)

Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Str., 31-324 Kraków, Poland.

Monika Kubacka (M)

Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Str., 30-688 Kraków, Poland.

Christophe Moreau (C)

Univ. Grenoble Alpes, CNRS, CEA, IBS, F-38000 Grenoble, France.

Maria Walczak (M)

Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Str., 30-688 Kraków, Poland.

Klaudia Blicharz-Futera (K)

Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Str., 30-688 Kraków, Poland.

Ophélie Bento (O)

IBMM, Université de Montpellier, CNRS, ENSCM, 34-293 Montpellier, France.
Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, 34-094 Montpellier, France.

Xavier Bantreil (X)

IBMM, Université de Montpellier, CNRS, ENSCM, 34-293 Montpellier, France.

Gilles Subra (G)

IBMM, Université de Montpellier, CNRS, ENSCM, 34-293 Montpellier, France.

Andrzej J Bojarski (AJ)

Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Str., 31-324 Kraków, Poland.

Frédéric Lamaty (F)

IBMM, Université de Montpellier, CNRS, ENSCM, 34-293 Montpellier, France.

Carine Becamel (C)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, 34-094 Montpellier, France.

Charleine Zussy (C)

Molecular Mechanisms in Neurodegenerative Dementia (MMDN) Laboratory, University of Montpellier, EPHE-PSL, INSERM U1198, 34-095 Montpellier, France.

Séverine Chaumont-Dubel (S)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, 34-094 Montpellier, France.

Piotr Popik (P)

Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Str., 31-324 Kraków, Poland.

Hugues Nury (H)

Univ. Grenoble Alpes, CNRS, CEA, IBS, F-38000 Grenoble, France.

Philippe Marin (P)

Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, 34-094 Montpellier, France.

Laurent Givalois (L)

Molecular Mechanisms in Neurodegenerative Dementia (MMDN) Laboratory, University of Montpellier, EPHE-PSL, INSERM U1198, 34-095 Montpellier, France.
Faculty of Medicine, Laval University, CR-CHUQ, G1 V 4G2 Québec City (QC), Canada.
CNRS, 75-016 Paris, France.

Paweł Zajdel (P)

Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Str., 30-688 Kraków, Poland.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH